TrialJournal of neurology2014

Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study.

Peter Joseph Jongen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.